These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21476319)

  • 1. Drug discovery projects. Preface.
    Lawton G; Witty DR
    Prog Med Chem; 2011; 50():v-vi. PubMed ID: 21476319
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicology Strategies for Drug Discovery - Present and Future: Introduction.
    Humphreys WG; Will Y; Guengerich FP
    Chem Res Toxicol; 2016 Apr; 29(4):437. PubMed ID: 27087588
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of modeling and simulation: myth or fact?
    Allerheiligen SR
    Clin Pharmacol Ther; 2014 Oct; 96(4):413-5. PubMed ID: 25236663
    [No Abstract]   [Full Text] [Related]  

  • 4. Ask the experts: computational chemistry.
    Matta CF; Hutter MC
    Future Med Chem; 2018 Jul; 10(13):1521-1524. PubMed ID: 29992825
    [No Abstract]   [Full Text] [Related]  

  • 5. Predicting drug side-effects by chemical systems biology.
    Tatonetti NP; Liu T; Altman RB
    Genome Biol; 2009; 10(9):238. PubMed ID: 19723347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best practices for metabolite quantification in drug development: updated recommendation from the European Bioanalysis Forum.
    Timmerman P; Blech S; White S; Green M; Delatour C; McDougall S; Mannens G; Smeraglia J; Williams S; Young G
    Bioanalysis; 2016 Jun; 8(12):1297-305. PubMed ID: 27217058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic applications of iminosugars: current perspectives and future opportunities.
    Horne G; Wilson FX
    Prog Med Chem; 2011; 50():135-76. PubMed ID: 21315930
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug discovery: Predicting promiscuity.
    Hopkins AL
    Nature; 2009 Nov; 462(7270):167-8. PubMed ID: 19907483
    [No Abstract]   [Full Text] [Related]  

  • 9. Mass spectrometry imaging in drug development.
    Nilsson A; Goodwin RJ; Shariatgorji M; Vallianatou T; Webborn PJ; Andrén PE
    Anal Chem; 2015 Feb; 87(3):1437-55. PubMed ID: 25526173
    [No Abstract]   [Full Text] [Related]  

  • 10. Practical approaches to resolving reactive metabolite liabilities in early discovery.
    Dalvie D; Kalgutkar AS; Chen W
    Drug Metab Rev; 2015 Feb; 47(1):56-70. PubMed ID: 25410913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial. Bioactivation of drugs: enzymes, reactive metabolites and adverse reactions.
    Orhan H
    Curr Med Chem; 2015; 22(4):406-7. PubMed ID: 25515506
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxicology Strategies for Drug Discovery: Present and Future.
    Blomme EA; Will Y
    Chem Res Toxicol; 2016 Apr; 29(4):473-504. PubMed ID: 26588328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of acid/base properties in drug discovery.
    Manallack DT; Prankerd RJ; Yuriev E; Oprea TI; Chalmers DK
    Chem Soc Rev; 2013 Jan; 42(2):485-96. PubMed ID: 23099561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The resurgence of covalent drugs.
    Singh J; Petter RC; Baillie TA; Whitty A
    Nat Rev Drug Discov; 2011 Apr; 10(4):307-17. PubMed ID: 21455239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective Application of Metabolite Profiling in Drug Design and Discovery.
    Cerny MA; Kalgutkar AS; Obach RS; Sharma R; Spracklin DK; Walker GS
    J Med Chem; 2020 Jun; 63(12):6387-6406. PubMed ID: 32097005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemical basis of pharmacology.
    Keiser MJ; Irwin JJ; Shoichet BK
    Biochemistry; 2010 Dec; 49(48):10267-76. PubMed ID: 21058655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failed Pediatric Drug Development Trials.
    Momper JD; Mulugeta Y; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):245-51. PubMed ID: 25963725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NICEdrug.ch, a workflow for rational drug design and systems-level analysis of drug metabolism.
    MohammadiPeyhani H; Chiappino-Pepe A; Haddadi K; Hafner J; Hadadi N; Hatzimanikatis V
    Elife; 2021 Aug; 10():. PubMed ID: 34340747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.
    Nicholson JK; Lindon JC; Holmes E
    Xenobiotica; 1999 Nov; 29(11):1181-9. PubMed ID: 10598751
    [No Abstract]   [Full Text] [Related]  

  • 20. De-risking drug discovery with ADDME -- avoiding drug development mistakes early.
    Tsaioun K; Jacewicz M
    Altern Lab Anim; 2009 Sep; 37 Suppl 1():47-55. PubMed ID: 19807206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.